VITR.ST
Price:
$242.4
Market Cap:
$32.82B
Vitrolife AB (publ), a medical device company, develops, produces, and markets products for assisted reproduction. It provides oocyte retrieval needles; sperm processing; in vitro fertilization media and oil; micromanipulation pipettes; labware; incubators; cryopreservation; and preimplantation genetic testing products. The company also offers EmbryoScope and Primo Vision time-lapse systems; time-lapse dishes; evaluation tools for time-lapse systems; and Octax laser and imaging systems, as well as log and guard systems and wireless sensors. It operates in Europe, the Middle East, and Africa; Asia; Japan and Pacific; and North and South America. The company was formerly known as Scandinavian ...[Read more]
Industry
Medical - Devices
IPO Date
2001-06-28
Stock Exchange
STO
Ticker
VITR.ST
According to Vitrolife AB (publ)’s latest financial reports and current stock price. The company's current Enterprise Value is 33.81B. This represents a change of 17.67% compared to the average of 28.74B of the last 4 quarters.
The mean historical Enterprise Value of Vitrolife AB (publ) over the last ten years is 21.05B. The current 33.81B Enterprise Value has changed 15.96% with respect to the historical average. Over the past ten years (40 quarters), VITR.ST's Enterprise Value was at its highest in in the December 2021 quarter at 60.77B. The Enterprise Value was at its lowest in in the December 2014 quarter at 3.27B.
Average
21.05B
Median
18.31B
Minimum
3.30B
Maximum
66.04B
Discovering the peaks and valleys of Vitrolife AB (publ) Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 193.34%
Maximum Annual Enterprise Value = 66.04B
Minimum Annual Increase = -59.33%
Minimum Annual Enterprise Value = 3.30B
Year | Enterprise Value | Change |
---|---|---|
2023 | 27.59B | 2.72% |
2022 | 26.86B | -59.33% |
2021 | 66.04B | 193.34% |
2020 | 22.51B | 8.11% |
2019 | 20.83B | 31.78% |
2018 | 15.80B | 19.57% |
2017 | 13.22B | 60.19% |
2016 | 8.25B | 35.00% |
2015 | 6.11B | 85.41% |
2014 | 3.30B | 77.79% |
The current Enterprise Value of Vitrolife AB (publ) (VITR.ST) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
40.16B
5-year avg
32.77B
10-year avg
21.05B
Vitrolife AB (publ)’s Enterprise Value is
Company | Enterprise Value | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vitrolife AB (publ) using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Vitrolife AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Vitrolife AB (publ)'s Enterprise Value?
What is the highest Enterprise Value for Vitrolife AB (publ) (VITR.ST)?
What is the 3-year average Enterprise Value for Vitrolife AB (publ) (VITR.ST)?
What is the 5-year average Enterprise Value for Vitrolife AB (publ) (VITR.ST)?
How does the current Enterprise Value for Vitrolife AB (publ) (VITR.ST) compare to its historical average?